Related Experiment Video
Updated: Jul 21, 2025

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Survival and Mortality in Hospitalized Children with COVID-19: A Referral Center Experience in Yazd, Iran
Farimah Shamsi1, Mehran Karimi2, Zahra Nafei2
1Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Insights
Male sex, lymphopenia, and hypoxia were key predictors of mortality in pediatric COVID-19 patients. Identifying these risk factors can improve survival rates for hospitalized children with COVID-19.
Area of Science:
- Pediatric infectious diseases
- Epidemiology of COVID-19
Background:
- COVID-19 (Coronavirus Disease 2019) prognostic risk factors, therapeutic protocols, and clinical outcomes in pediatric cases require further investigation.
- Understanding pediatric COVID-19 outcomes is crucial for developing effective treatment strategies.
Purpose of the Study:
- To evaluate the survival time and identify prognostic risk factors for hospitalized children diagnosed with COVID-19.
- To inform clinical decision-making and improve survival rates in pediatric COVID-19 cases.
Main Methods:
- A historical cohort study was conducted involving hospitalized children aged 1 month to 18 years with COVID-19.
- Data were collected from March 2020 to August 2021, with a minimum one-month follow-up after discharge.
- Bayesian Cox regression analysis was employed to identify significant predictors of survival time.
Main Results:
- Out of 183 hospitalized children, 24 (13.1%) deceased. The overall one-month survival rate was 0.88.
- Significant predictors of reduced survival included male sex, prior hospitalization history, lymphopenia, hypoxia, and a length of stay exceeding two weeks.
- The median age of the study population was 5.41 years, with 54.2% being male.
Conclusions:
- Identifying key predictors of poor outcomes in pediatric COVID-19 is essential for optimizing therapeutic protocols.
- Risk stratification based on factors like sex, lymphopenia, and hypoxia can aid healthcare providers in tailoring treatments to individual patient needs.
- This study highlights the importance of considering specific clinical and laboratory findings to improve survival in hospitalized children with COVID-19.
Introduction:
COVID-19 prognostic risk factors, therapeutic protocols, and clinical outcomes in pediatric cases are still under investigation.
Materials And Methods:
This historical cohort study evaluated the survival time of hospitalized children (1 month-18 years old) with COVID-19 admitted from March 2020 to August 2021 to an educational hospital in Yazd, Iran. The follow-up of patients was performed at least one month after discharge.
Results:
From 183 hospitalized cases, 24 children were deceased. The median age of patients was 5.41, and 54.2% were male. The survival rate after one-month follow-up was 0.88, and the most significant predictors associated with survival time were the male sex, positive history of hospitalization, lymphopenia, hypoxia, and length of stay more than two weeks using Bayesian Cox regression analysis.
Conclusion:
Accurate estimation of the impact of predictors on poor outcomes may help healthcare providers use therapeutic protocols based on risk factors and healthcare requirements of each patient to improve their survival.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Assumptions of Survival Analysis
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...

